(A–C) Compilation of the ATAC-seq data (Figure 1) and the RNA-seq data (Figure 2). (A) Dot blots represent the fold difference
of mRNA expression (CPT 4 h/0 h) (y axis) and fold difference of ATAC-seq score
(CPT 4 h/0 h) (x axis) in CCRF-CEM parent (left) and SLFN11-KO cells (right).
Three representative IEGs are annotated. Upregulated (>2-fold and p
< 1E-07) and downregulated (< −2-fold and p < 1E-07)
genes are colored in red and blue, respectively. (B) Dot blots representing gene
length (bp) of the upregulated (up) and downregulated (down) genes compared to
all genes (all). (C) Dot blots representing basal mRNA expression level (y axis)
and basal ATAC-seq score (x axis) for each gene (left). Each parameter is
replotted on the right panels for all the upregulated (up) and downregulated
(down) genes.
(D) Dot plots representing H3K27 acetylation levels in basal condition
(x axis) and after drug treatment (CPT 100 nM for 4 h, y axis). Each point
represents the intensity of ChIP-seq peaks of the 2 conditions. The black, red,
and blue lines indicate no difference, 2-fold increase, and 2-fold decrease,
respectively. The hyperacetylated IEGs (>2-fold) at their promoters are
annotated and highlighted in red.
(E) Sequencing tracks around the NFKB2 locus for the
indicated conditions in CCRF-CEM parent and SLFN11-KO.
(F) Enrichment of the active histone mark H3K27Ac around the
NFKB2 locus was examined by ChIP assay in CCRF-CEM parental
cells with or without CPT treatment (250 nM or 1,000 nM, 4 h). The loci of
primer sets for ChIP qPCR are shown at the bottom of (E). Results are
representative of three independent experiments and the average of three
technical repeats with ± SD. **p ≤ 0.01, ***p ≤ 0.001
(two-tailed unpaired t test).
See also Figure
S4 and Table
S6.